Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
120 participants
INTERVENTIONAL
2007-03-31
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Posterior Capsule Opacification Study
NCT00312299
Safety and Surgical Performance Study of Aurosleek Surgical Blades
NCT01763593
Posterior Capsule Opacification (PCO) With Single Piece Hydrophobic Versus Hydrophillic Intraocular Lens (IOL)
NCT01125345
Ologen (OculusGen)-Glaucoma Case Control Trial in India
NCT00448929
Comparison of In-the-bag Stability Between Single-piece and Three-piece Intraocular Lens
NCT02609997
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Intraocular Lens
Phacoemulsification with in the bag implantation of the IOL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intraocular Lens
Phacoemulsification with in the bag implantation of the IOL
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Senile Cataract
* Posterior Subcapsular Cataract (PSCC)
Exclusion Criteria
* Cardiac and other serious illness
* Diabetic Patients
* Traumatic cataract
* Complicated cataract
* Congenital cataract
* Drug induced cataract
* Shallow anterior chamber
* Poor mydriasis
* Amblyopia
* Pseudo exfoliation (PXF)
* Dense posterior polar cataract (PPC)
* One eyed patients
* Glaucoma
* Uveitis
* Corneal Pathology
* Retinal Pathology
* Intra operative complications like PC rupture, Zonular dialysis
40 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aurolab
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aravind Eye Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Haripriya Aravind, MBBS, MS
Role: PRINCIPAL_INVESTIGATOR
Aravind Eye Hospital, Madurai
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aravind Eye Hospital
Madurai, Tamil Nadu, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1PN1010614
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.